{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:24Z","timestamp":1786997844896,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2020.01.048","type":"journal-article","created":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T07:41:31Z","timestamp":1579938091000},"page":"2117-2121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries"],"prefix":"10.1016","volume":"38","author":[{"given":"Susan L.","family":"Hills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad J.","family":"Biggerstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.048_b0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2020.01.048_b0010","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4269\/ajtmh.2010.09-0676","article-title":"Japanese encephalitis in travelers from non-endemic countries, 1973\u20132008","volume":"82","author":"Hills","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.01.048_b0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.048_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese encephalitis vaccine: recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2020.01.048_b0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.15585\/mmwr.mm6622a3","article-title":"Japanese encephalitis surveillance and immunization - Asia and Western Pacific regions, 2016","volume":"66","author":"Heffelfinger","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.01.048_b0030","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.01.048_b0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/INF.0000000000001615","article-title":"Immunogenicity of the inactivated Japanese encephalitis virus vaccine IXIARO in children from a Japanese encephalitis virus-endemic region","volume":"36","author":"Dubischar","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.01.048_b0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.048_b0045","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2018.04.038","article-title":"Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012\u20132016","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.048_b0050","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.vaccine.2010.07.040","article-title":"Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO\u00ae (IC51), in 6 months of follow-up","volume":"28","author":"Dubischar-Kastner","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.048_b0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jtm.12056","article-title":"Acceptability of hypothetical dengue vaccines among travelers","volume":"20","author":"Benoit","year":"2013","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.01.048_b0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.vaccine.2018.01.004","article-title":"German travelers' preferences for travel vaccines assessed by a discrete choice experiment","volume":"36","author":"Poulos","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.048_b0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12936-015-0654-y","article-title":"Recommendations for malaria prevention in moderate to low risk areas: travellers\u2019 choice and risk perception","volume":"14","author":"Voumard","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2020.01.048_b0070","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.15585\/mmwr.mm6745a4","article-title":"ACIP evidence-based recommendations work group. Updated framework for development of evidence-based recommendations by the advisory committee on immunization practices","volume":"67","author":"Lee","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.01.048_b0075","unstructured":"Growth from Knowledge (GfK). KnowledgePanel\u00ae. A Methodological Overview. Available at: https:\/\/www.gfk.com\/fileadmin\/user_upload\/dyna_content\/US\/documents\/KnowledgePanel_-_A_Methodological_Overview.pdf. Accessed January 7, 2020."},{"key":"10.1016\/j.vaccine.2020.01.048_b0080","unstructured":"United States Census Bureau. Current Population Survey. Available at: https:\/\/www.census.gov\/programs-surveys\/cps.html. Accessed May 9, 2019."},{"key":"10.1016\/j.vaccine.2020.01.048_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jssam\/smu021","article-title":"AIC and BIC for modeling with complex survey data","volume":"3","author":"Lumley","year":"2015","journal-title":"J Surv Stat Methodol"},{"key":"10.1016\/j.vaccine.2020.01.048_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples","volume":"9","author":"Lumley","year":"2004","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2020.01.048_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1440-1754.2009.01494.x","article-title":"Varicella immunisation practice: implications for provision of a recommended, non-funded vaccine","volume":"45","author":"Marshall","year":"2009","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2020.01.048_b0100","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4161\/hv.27243","article-title":"Epidemiology of vaccine hesitancy in the United States","volume":"9","author":"Siddiqui","year":"2013","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:25Z","timestamp":1759401625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20300748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X20300748"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}